BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
Number Citing Articles
1 Ryan CS, Schröder M. The human DEAD-box helicase DDX3X as a regulator of mRNA translation. Front Cell Dev Biol 2022;10. [DOI: 10.3389/fcell.2022.1033684] [Reference Citation Analysis]
2 Prins H, Crespo R, Lungu C, Rao S, Li L, Overmars R, Papageorgiou G, Mueller Y, Hossain T, Kan T, Rijnders B, Bax H, van Gorp E, Nouwen J, de Vries-sluijs T, Schurink C, de Mendonça Melo M, van Nood E, Colbers A, Burger D, Palstra R, van Kampen J, van de Vijver D, Mesplède T, Katsikis P, Gruters R, Koch B, Verbon A, Mahmoudi T, Rokx C. The BAF complex inhibitor pyrimethamine reverses HIV-1 latency in people with HIV-1 on antiretroviral therapy.. [DOI: 10.1101/2022.09.23.22280188] [Reference Citation Analysis]
3 Rao S. Sex differences in HIV-1 persistence and the implications for a cure. Front Glob Womens Health 2022;3. [DOI: 10.3389/fgwh.2022.942345] [Reference Citation Analysis]
4 Nakano K, Watanabe T. Tuning Rex rules HTLV-1 pathogenesis. Front Immunol 2022;13:959962. [DOI: 10.3389/fimmu.2022.959962] [Reference Citation Analysis]
5 Tanaka K, Kim Y, Roche M, Lewin SR. The role of latency reversal in HIV cure strategies. J Med Primatol 2022. [PMID: 36029233 DOI: 10.1111/jmp.12613] [Reference Citation Analysis]
6 Kwon J, Choi H, Han C. A Dual Role of DDX3X in dsRNA-Derived Innate Immune Signaling. Front Mol Biosci 2022;9:912727. [PMID: 35874614 DOI: 10.3389/fmolb.2022.912727] [Reference Citation Analysis]
7 Campbell GR, Spector SA. Current strategies to induce selective killing of HIV-1-infected cells. J Leukoc Biol 2022. [PMID: 35707952 DOI: 10.1002/JLB.4MR0422-636R] [Reference Citation Analysis]
8 Crespo R, Rao S, Mahmoudi T. HibeRNAtion: HIV-1 RNA Metabolism and Viral Latency. Front Cell Infect Microbiol 2022;12:855092. [DOI: 10.3389/fcimb.2022.855092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Rao S, Mahmoudi T. DEAD-ly Affairs: The Roles of DEAD-Box Proteins on HIV-1 Viral RNA Metabolism. Front Cell Dev Biol 2022;10:917599. [DOI: 10.3389/fcell.2022.917599] [Reference Citation Analysis]
10 Ne E, Crespo R, Izquierdo-Lara R, Rao S, Koçer S, Górska A, van Staveren T, Kan TW, van de Vijver D, Dekkers D, Rokx C, Moulos P, Hatzis P, Palstra RJ, Demmers J, Mahmoudi T. Catchet-MS identifies IKZF1-targeting thalidomide analogues as novel HIV-1 latency reversal agents. Nucleic Acids Res 2022:gkac407. [PMID: 35640596 DOI: 10.1093/nar/gkac407] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Labaronne E, Décimo D, Bertrand L, Guiguettaz L, Sohier TJ, Cluet D, Vivet-boubou V, Dahoui C, François P, Hatin I, Lambotte O, Samri A, Autran B, Etienne L, Goujon C, Paillart J, Namy O, Ramirez BC, Ohlmann T, Moris A, Ricci EP. Extensive uORF translation from HIV-1 transcripts conditions DDX3 dependency for expression of main ORFs and elicits specific T cell immune responses in infected individuals.. [DOI: 10.1101/2022.04.29.489990] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Chen M, Li M, Budai MM, Rice AP, Kimata JT, Mohan M, Wang J. Clearance of HIV-1 or SIV reservoirs by promotion of apoptosis and inhibition of autophagy: Targeting intracellular molecules in cure-directed strategies. J Leukoc Biol 2022. [PMID: 35362118 DOI: 10.1002/JLB.4MR0222-606] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Freen-van Heeren JJ. Flow-FISH as a Tool for Studying Bacteria, Fungi and Viruses. BioTech 2021;10:21. [DOI: 10.3390/biotech10040021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Kang W, Sun Y. Moving Toward a Functional Cure for HIV-1. Infectious Diseases & Immunity 2021;1:161-168. [DOI: 10.1097/id9.0000000000000025] [Reference Citation Analysis]
15 Chen CJ, Chiu ML, Hung CH, Liang WM, Ho MW, Lin TH, Liu X, Tsang H, Liao CC, Huang SM, Wu YF, Wu YC, Li TM, Tsai FJ, Lin YJ. Effect of Xanthium Strumarium on HIV-1 5'-LTR Transcriptional Activity and Viral Reactivation in Latently Infected Cells. Front Pharmacol 2021;12:720821. [PMID: 34421615 DOI: 10.3389/fphar.2021.720821] [Reference Citation Analysis]
16 Campbell GR, Spector SA. Induction of Autophagy to Achieve a Human Immunodeficiency Virus Type 1 Cure. Cells 2021;10:1798. [PMID: 34359967 DOI: 10.3390/cells10071798] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Lungu C, Banga R, Gruters RA, Procopio FA. Inducible HIV-1 Reservoir Quantification: Clinical Relevance, Applications and Advancements of TILDA. Front Microbiol 2021;12:686690. [PMID: 34211450 DOI: 10.3389/fmicb.2021.686690] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Hernández-Díaz T, Valiente-Echeverría F, Soto-Rifo R. RNA Helicase DDX3: A Double-Edged Sword for Viral Replication and Immune Signaling. Microorganisms 2021;9:1206. [PMID: 34204859 DOI: 10.3390/microorganisms9061206] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
19 Ne E, Crespo R, Izquierdo-lara R, Rao S, Koçer S, Górska A, van Staveren T, Kan TW, Dekkers D, Rokx C, Moulos P, Hatzis P, Palstra R, Demmers J, Mahmoudi T. Catchet-MS identifies IKZF1-targeting Thalidomide analogues as novel HIV-1 latency reversal agents.. [DOI: 10.1101/2021.03.19.436149] [Reference Citation Analysis]